U.S. Metals and Mining Stock News

Journey Medical (DERM) closed FY 2025 with Q4 revenue of US$16.1 million and a basic EPS loss of US$0.05, while trailing twelve month figures show revenue of US$61.9 million and a basic EPS loss of US$0.47. Over recent quarters, revenue has ranged from US$13.1 million in Q1 2025 to US$17.6 million in Q3 2025, with basic EPS moving between a loss of US$0.18 and a loss of US$0.05. This sets up a story in which top line scale is building while margins remain under pressure. See our full analysis...

First National (FXNC) has reported FY 2025 results with fourth quarter revenue of US$23.0 million and EPS of US$0.61, capping a trailing twelve month revenue line of US$87.0 million and EPS of US$1.97 that reflects 154.1% earnings growth over the past year. Over recent periods, revenue has moved from US$13.3 million in Q3 2024 to US$17.1 million in Q4 2024 and then to US$23.0 million in Q4 2025. Quarterly EPS shifted from a loss of US$0.10 in Q4 2024 to US$0.61 in Q4 2025, highlighting a...

Amaroq Q3 2025 earnings snapshot Amaroq (OTCPK:AMRQ.F) has just reported Q3 2025 results with revenue of C$12.8 million and a basic EPS loss of C$0.0117, alongside trailing twelve month revenue of C$16.3 million and a basic EPS loss of C$0.0511. Over recent quarters the company has seen revenue move from C$0 in Q3 2024 to C$3.4 million in Q2 2025 and then to C$12.8 million in Q3 2025, while quarterly basic EPS has ranged between a loss of C$0.0428 and a loss of C$0.0111 across the same...

KalVista Pharmaceuticals (KALV) closed FY 2025 with fourth quarter revenue of US$59.9 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$5.4 million loss. This provides a clear snapshot of a business still in investment mode. The company has seen quarterly revenue shift from US$13.7 million in FY 2025 Q3 to US$59.9 million in FY 2025 Q4, while basic EPS moved from a US$0.92 loss to a US$0.10 loss over the same period, highlighting a set of results...

H.B. Fuller (FUL) opened Q1 2026 with total revenue of US$770.8 million and basic EPS of US$0.38, against a backdrop of trailing twelve month revenue of US$3.5 billion and basic EPS of US$2.93 that has been supported by 41.8% earnings growth over the last year. Over recent quarters, the company has seen quarterly revenue move from US$788.7 million in Q1 2025 to US$894.8 million in Q4 2025 before landing at US$770.8 million in Q1 2026. Basic EPS over that span ranged from US$0.24 to US$1.23,...

GameStop (GME) has just wrapped up FY 2026 with fourth quarter revenue of US$1,104.3 million and basic EPS of US$0.29 on net income of US$127.9 million, capping a twelve month period where trailing revenue was US$3,629.9 million and EPS reached US$0.93 on net income of US$418.4 million. Across the year, quarterly revenue moved between US$732.4 million and US$1,104.3 million while basic EPS ranged from US$0.10 to US$0.38. This provides a clearer view of how the top line and per share earnings...

Caesars Entertainment (NasdaqGS:CZR) is converting The Cromwell on the Las Vegas Strip into The Vanderpump Hotel. The new boutique property is positioned around Lisa Vanderpump's hospitality brand and design concepts. The launch introduces a non gaming focused draw within Caesars' broader Las Vegas portfolio. For Caesars Entertainment, the move fits with a broader shift in Las Vegas toward high profile branded hospitality concepts, where food, beverage and design carry as much weight as...

JBS (NYSE:JBS) FY 2025 earnings snapshot JBS (NYSE:JBS) has reported its FY 2025 numbers with Q4 revenue of US$23.1 billion and basic EPS of US$0.43, alongside trailing twelve month EPS of US$1.89 on revenue of US$86.2 billion, setting the stage for a closer look at how the year stacked up. Over recent periods the company has seen quarterly revenue move from US$22.6 billion in Q3 2025 to US$23.1 billion in Q4 2025, while quarterly basic EPS shifted from US$0.52 to US$0.43 and annual earnings...

SFL Corporation announced that it has secured a drilling agreement in Canada for its semi-submersible rig Hercules, an estimated US$170 million contract for a minimum of 400 days, with Odfjell Drilling to operate the unit after preparation in Norway. This contract meaningfully enhances visibility on future rig utilization and cash inflows from Hercules, a previously idle asset highlighted as a risk in the earlier investment narrative. We’ll examine how this new US$170 million Hercules...

DHT Holdings (NYSE:DHT) has filed a universal shelf registration statement covering multiple classes of securities. The filing allows the company to issue common stock, preferred stock, warrants, and rights over time as needed. This structure is designed to give DHT Holdings more flexibility in how and when it raises capital. DHT Holdings operates in the tanker shipping sector, a part of the energy supply chain that often responds directly to global trade flows and oil transport demand. A...

Ondas Holdings (NasdaqCM:ONDS) agreed to acquire U.S. defense prime contractor Mistral Inc. in a cash and stock deal valued at about $175m. The company reported a $15.8m demining order linked to this transition into prime contractor roles within U.S. defense programs. Ondas expanded its partnership with Palantir to support AI powered, multi domain intelligence and ISR infrastructure across its platforms. For investors following defense technology, Ondas has mostly been known for...

Globus Medical (NYSE:GMED) has announced that board director John A. DeFord is stepping down from its Board of Directors with immediate effect. DeFord served on the board during key corporate events, including the NuVasive merger, making this governance change a fresh development for shareholders to assess. Globus Medical, trading at $87.35 as of the last close, has seen its share price move 17.5% over the past year and 63.4% over the past 3 years. Recent attention around NYSE:GMED has...

Why Park Hotels & Resorts is on investors’ radar Park Hotels & Resorts (PK) has drawn fresh attention after its latest annual figures showed revenue of US$2,545.0 million alongside a net income loss of US$283.0 million, prompting investors to reassess this lodging REIT. See our latest analysis for Park Hotels & Resorts. At a share price of US$10.60, Park Hotels & Resorts has seen short-term pressure, with a 1-month share price return of a 4.5% decline, even though the 3-year total shareholder...

TransMedics Group expanded its National Organ Care System Program, aiming to handle a larger share of U.S. transplant procedures. The company is advancing kidney and lung transplant initiatives, including full control of the ENHANCE clinical trial. TransMedics is preparing simultaneous U.S. and Europe clinical trial launches for its kidney program as part of a broader transplant platform push. TransMedics Group, NasdaqGM:TMDX, is pushing beyond its medical device roots toward a more...

AngloGold Ashanti (NYSE:AU) has released a Technical Report Summary for its Arthur Gold Project in Nevada. The report identifies Arthur as a Tier One gold deposit. New Probable Mineral Reserves have been established for the project. AngloGold Ashanti plans to progress Arthur towards a full feasibility study following this report. For investors following gold producers, AngloGold Ashanti is a large, diversified miner with assets across several regions, and Arthur adds another project in a...

Wondering if California Water Service Group at around US$43.94 is offering fair value right now, or if the price is out of line with what you are actually getting. The stock is up 1.5% over the last 7 days and 2.3% year to date, but it has seen a 5.3% decline over 30 days and a 2.7% decline over the past year, which can change how the market is weighing risk and return. Recent coverage has focused on how regulated utilities like California Water Service Group respond to changing funding...

Permian Basin Royalty Trust (NYSE:PBT) has announced a dividend decrease. The change affects upcoming distributions to unitholders and updates the trust's income profile. Permian Basin Royalty Trust holds royalty interests in oil and gas properties, so its cash distributions are closely tied to production volumes and commodity prices. A dividend adjustment like this can signal that recent cash receipts from underlying properties differ from prior periods. For income focused investors, the...

Cadence Design Systems (NasdaqGS:CDNS) has appointed Dr. Alok Jain as Managing Director for India. The appointment positions India as a key innovation and R&D hub for the company’s semiconductor and design software efforts. Dr. Jain is expected to focus on relationships across government, academia, and industry within India’s growing chip ecosystem. Cadence Design Systems, a major player in electronic design automation and semiconductor IP, is putting more executive weight behind India as a...

Valero Energy (NYSE:VLO) is facing a worker lawsuit that alleges negligence after the recent explosion at its Port Arthur refinery. The suit claims gross negligence related to safety practices and working conditions at one of Valero's largest facilities. This legal action adds fresh scrutiny to the company's operational risk management and potential liability exposure. Valero is one of the largest independent refiners in the US, with operations that supply transportation fuels and other...

If you are wondering whether BioCryst Pharmaceuticals at US$9.40 still offers value, it helps to start by lining up the recent share performance with what the fundamentals suggest the stock might be worth. Over the short term, the share price return sits at 2.6% over 7 days, 24.0% over 30 days and 25.3% year to date, with a 20.5% return over 1 year and 9.8% over 3 years, compared with a 5 year return of a 7.6% decline. These moves are occurring as investors continue to respond to ongoing...

Over the last 7 days, the United States market has remained flat, yet it has risen by 16% over the past year with expectations of earnings growing annually by a similar rate in the coming years. In this context of steady growth, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and potential to outperform these promising market conditions.

In the last week, the United States market has stayed flat, although it is up 16% over the past year with earnings forecasted to grow by 16% annually. In this environment, identifying stocks trading below their estimated intrinsic value can present opportunities for investors seeking potential growth at a reasonable price.

In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by 16%, with earnings forecasted to grow at a similar rate annually. In this context of steady growth, stocks with strong insider ownership can be particularly appealing as they often indicate confidence in a company's future prospects and alignment between management and shareholders.

Central Bancompany (CBC) has just been added to a wide range of Russell value and broad market indexes, an inclusion that often shifts how institutional investors and index funds look at the stock. See our latest analysis for Central Bancompany. At a share price of US$23.72, Central Bancompany has seen modest short term softness, with a 30 day share price return of a 2.43% decline. However, the 1 year total shareholder return of 73.02% and 5 year total shareholder return of 134.52% point to...